NCT05162599View on ClinicalTrials.gov

Evaluation of Cardiags Trimod for Analysis of Cardiac Activity

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 8, 2022

Primary Completion Date

June 8, 2023

Study Completion Date

June 8, 2023

Conditions
Murmur, HeartRhythm; Abnormal
Interventions
DEVICE

Diagnostic study, experimental evaluative cross-sectional study

This is a cross-sectional diagnostic study with collection of information from the gold standard (or reference test) and the new device

Trial Locations (1)

69005

Hôpital de Fourvière, Lyon

Sponsors

Lead Sponsor

CARDIAGS
All Listed Sponsors
lead

CARDIAGS

INDUSTRY

NCT05162599 - Evaluation of Cardiags Trimod for Analysis of Cardiac Activity | Biotech Hunter | Biotech Hunter